Quarterly report [Sections 13 or 15(d)]

EARNINGS PER SHARE (Tables)

v3.25.3
EARNINGS PER SHARE (Tables)
9 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
SCHEDULE OF ANTI DILUTIVE SECURITIES

The following potentially dilutive securities were excluded from the calculation of diluted net loss per share because the effects were anti-dilutive based on the application of the treasury stock method and because the Company incurred net losses during the period:

 

    2025     2024     2025     2024  
    For the Nine Months Ended
September 30,
    For the Three Months Ended
September 30,
 
    2025     2024     2025     2024  
Convertible notes payable     1,774,896       509,504       1,774,896       509,504  
Preferred stock     641,577       301,900       641,577       301,900  
Restricted stock units     90,473       41,566       90,473       12,424  
Warrants to purchase shares of common stock     43,438       251,125       43,438       251,125  
Total potentially dilutive shares     2,550,383       1,104,095       2,550,383       1,074,953  
SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET INCOME PER SHARE

The following table sets forth the computation of basic and diluted net loss per share:

 

    2025     2024     2025     2024  
    Nine Months Ended September 30,     Three Months Ended September 30,  
    2025     2024     2025     2024  
                         
Net loss attributable to the common stockholders   $ (2,698,254 )   $ (2,817,394 )   $ (578,503 )   $ (1,196,923 )
                                 
Basic weighted average outstanding shares of common stock     1,605,377       1,245,885       1,605,377       1,268,795  
Dilutive effect of options and warrants     -       -       -       -  
Diluted weighted average common stock and common stock equivalents     1,605,377       1,245,885       1,605,377       1,268,795  
                                 
Loss per share:                                
Basic and diluted   $ (1.68 )   $ (2.26 )   $ (0.36 )   $ (0.94 )